Last reviewed · How we verify

NCT04298151

Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

Completed Phase 2 Last updated 6 February 2024
What this trial tests

Phase 2 trial testing Zirconomer Improved in Geriatric in 28 participants. Completed in 1 October 2022.

Timeline
1 September 2021
Primary endpoint
1 September 2022
1 October 2022

Quick facts

Lead sponsorCairo University
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment28
Start date1 September 2021
Primary completion1 September 2022
Estimated completion1 October 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 60 to 80, any sex, with Geriatric or Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Self-Therapeutic Nanomaterials: Applications in Biology and Medicine.
    Seaberg J, Clegg JR, Bhattacharya R, Mukherjee P. · · 2023 · cited 28× · PMID 36938366 · DOI 10.1016/j.mattod.2022.11.007
  2. Clinical Performance of Zirconia Reinforced versus Conventional Viscous Glass Ionomer in Class I Cavities of Geriatric Patients: A 1-year Randomized Controlled Clinical Trial.
    Abdou D, Akah M, Mosallam RS, Safwat OM. · · 2024 · cited 2× · PMID 39206240 · DOI 10.4103/ccd.ccd_440_23

Verify or expand the search:

Other trials of Zirconomer Improved

Trials testing the same drug.

Other recruiting trials for Geriatric

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04298151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing